{"gene":"RAB3GAP2","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":2014,"finding":"RAB3GAP1 and RAB3GAP2 form a complex (RAB3GAP complex) that modulates autophagosomal biogenesis at basal and rapamycin-induced conditions; their autophagy modulatory activity depends on the GTPase-activating activity of RAB3GAP1 but is independent of the RAB GTPase RAB3. Significant levels of RAB3GAP1/2 colocalize with Atg8 family members at lipid droplets.","method":"C. elegans genetics and human primary fibroblasts; correlation with ATG3, ATG16L1, ATG5 puncta analysis; colocalization imaging; epistasis with FEZ1/FEZ2","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (genetic epistasis in C. elegans, fibroblast KD, colocalization, autophagy marker analysis), single lab","pmids":["25495476"],"is_preprint":false},{"year":2017,"finding":"FOXC1 positively regulates RAB3GAP2 (and RAB3GAP1) expression, and this regulation affects secretion of Myocilin (MYOC); modulation of RAB3GAP2 expression by FOXC1 links it to exocytosis/endocytosis pathways relevant to glaucoma.","method":"Biochemical and molecular techniques including gene expression manipulation (FOXC1 level alteration) and MYOC secretion assays in ocular cell lines","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — multiple biochemical/molecular methods in one lab; transcriptional regulation and secretion assays, but no direct mechanistic reconstitution of RAB3GAP2 activity","pmids":["28575017"],"is_preprint":false},{"year":2026,"finding":"RAB3GAP2 is expressed predominantly in skeletal muscle microvascular endothelium and acts as a negative regulator of endothelial cell proliferation and angiogenesis; experimental knockdown of RAB3GAP2 in human endothelial cells increased proliferation, tube formation in vitro, and in vivo endothelial cell density in mice, and regulated secreted angiogenic factors (CD70, TNC), possibly mediated through RAB18.","method":"siRNA knockdown in human endothelial cells; in vitro proliferation and tube formation assays; in vivo mouse endothelial density measurement; secretome/proteomics of conditioned medium; eQTL analysis; immunofluorescence localization","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined cellular phenotype, in vitro and in vivo validation, secretome analysis, single lab","pmids":["41678332"],"is_preprint":false},{"year":2025,"finding":"RAB3GAP2 silencing in lens epithelial cell cataract models activates the JNK/STAT3 signaling pathway, increasing Mfn2 transcription and promoting Mfn2-mediated mitochondrial autophagy, thereby reducing oxidative stress and apoptosis; inhibition of JNK (SP600125) or Mfn2 silencing abrogated these effects both in vitro and in a mouse cataract model.","method":"siRNA silencing in NaIO3-induced cataract cell models and mouse cataract model; RNA sequencing; JNK inhibitor (SP600125); Mfn2 siRNA; ROS and mitochondrial membrane potential assays; STAT3 nuclear translocation; in vivo mouse experiments","journal":"International journal of biological macromolecules","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal in vitro and in vivo methods with inhibitor and genetic rescue controls, single lab","pmids":["41271057"],"is_preprint":false},{"year":2026,"finding":"A RAB3GAP2 splice site variant (c.304+5G>T) causes aberrant splicing with exon 3 skipping, demonstrated by RT-PCR in patient leukocytes and a minigene assay in HEK293T and HeLa cells, predicting a truncated, loss-of-function protein.","method":"RT-PCR on patient peripheral blood; minigene splicing assay in HEK293T and HeLa cells; bioinformatics splice prediction tools","journal":"BMC medical genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — minigene functional assay with patient RT-PCR confirmation, two cell lines tested, single lab","pmids":["42106822"],"is_preprint":false},{"year":2013,"finding":"Genotype-phenotype analysis of mutations in RAB3GAP1, RAB3GAP2, and RAB18 established that loss-of-function mutations in RAB3GAP2 cause Warburg Micro syndrome, while hypomorphic (milder) RAB3GAP2 mutations cause the less severe Martsolf syndrome, indicating a phenotypic severity continuum determined by the nature of the mutation and residual protein function.","method":"Mutational analysis of 144 Micro and 9 Martsolf families; Leiden Open source Variation Database curation; genotype-phenotype correlation","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 3 / Strong — large multi-family genetic study establishing genotype-phenotype relationships, replicated across many families, but no direct biochemical functional assay of RAB3GAP2 activity","pmids":["23420520"],"is_preprint":false},{"year":2010,"finding":"A homozygous in-frame deletion in RAB3GAP2 (p.Phe167_Thr169del) causes Warburg Micro syndrome, demonstrating that functionally severe RAB3GAP2 mutations (not only hypomorphic ones) can produce the full Micro syndrome phenotype, establishing that RAB3GAP2 loss-of-function severity determines clinical outcome.","method":"Sanger sequencing of RAB3GAP2 in a consanguineous family; clinical phenotyping","journal":"Human genetics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single family genetic finding, no direct biochemical assay of mutant protein function","pmids":["20967465"],"is_preprint":false}],"current_model":"RAB3GAP2 is the non-catalytic regulatory subunit of the RAB3GAP complex (with RAB3GAP1 as the catalytic subunit); together they act as a GTPase-activating protein for RAB3 in regulated exocytosis of neurotransmitters and hormones, modulate autophagosomal biogenesis in a RAB3-independent but RAB3GAP1 GTPase activity-dependent manner, function as a negative regulator of endothelial cell proliferation and angiogenesis (possibly via RAB18), and in lens cells suppress oxidative stress by restraining JNK/STAT3-driven Mfn2-mediated mitochondrial autophagy; loss-of-function or hypomorphic mutations in RAB3GAP2 cause Warburg Micro syndrome or the milder Martsolf syndrome depending on the severity of residual protein function."},"narrative":{"mechanistic_narrative":"RAB3GAP2 is a regulatory component of the RAB3GAP complex that links RAB GTPase regulation to autophagy, secretion, and vascular and lens cell homeostasis [PMID:25495476, PMID:41678332]. Together with RAB3GAP1, it modulates autophagosomal biogenesis under basal and rapamycin-induced conditions in a manner that depends on the GTPase-activating activity of RAB3GAP1 but is independent of RAB3, with the complex colocalizing with Atg8-family members at lipid droplets [PMID:25495476]. Its expression is positively controlled by the transcription factor FOXC1, coupling it to Myocilin secretion and ocular exocytic/endocytic pathways relevant to glaucoma [PMID:28575017]. In skeletal muscle microvascular endothelium, RAB3GAP2 acts as a negative regulator of endothelial proliferation and angiogenesis, restraining tube formation and the secretion of angiogenic factors including CD70 and TNC, possibly through RAB18 [PMID:41678332]. In lens epithelial cells it suppresses oxidative stress and apoptosis by restraining JNK/STAT3 signaling that drives Mfn2 transcription and Mfn2-mediated mitochondrial autophagy [PMID:41271057]. Loss-of-function mutations in RAB3GAP2 cause Warburg Micro syndrome, whereas milder hypomorphic mutations cause Martsolf syndrome, defining a severity continuum set by residual protein function [PMID:23420520, PMID:20967465].","teleology":[{"year":2010,"claim":"Establishing that a severe RAB3GAP2 lesion can produce disease addressed whether RAB3GAP2 mutation alone causes the full Micro syndrome phenotype.","evidence":"Sanger sequencing of an in-frame deletion in a consanguineous family with clinical phenotyping","pmids":["20967465"],"confidence":"Low","gaps":["Single family; no biochemical assay of the mutant protein's activity","Does not define the molecular function disrupted by the deletion"]},{"year":2013,"claim":"Genotype-phenotype correlation across many families resolved how mutation severity maps onto clinical outcome, establishing the Micro/Martsolf continuum.","evidence":"Mutational analysis of 144 Micro and 9 Martsolf families with variant database curation","pmids":["23420520"],"confidence":"Medium","gaps":["No direct biochemical assay of RAB3GAP2 activity","Mechanism connecting residual function to phenotype severity not defined"]},{"year":2014,"claim":"Demonstrating that the RAB3GAP complex modulates autophagosome biogenesis revealed a cellular function beyond RAB3 regulation, dependent on RAB3GAP1 catalytic activity but independent of RAB3.","evidence":"C. elegans genetics, human fibroblast knockdown, autophagy marker puncta analysis, and lipid droplet colocalization","pmids":["25495476"],"confidence":"Medium","gaps":["The relevant RAB substrate for autophagy is unidentified","Specific contribution of RAB3GAP2 versus RAB3GAP1 to the autophagy phenotype not separated"]},{"year":2017,"claim":"Identifying FOXC1 as a positive regulator of RAB3GAP2 expression connected the gene to transcriptional control of ocular secretion and glaucoma-relevant Myocilin handling.","evidence":"FOXC1 level manipulation and Myocilin secretion assays in ocular cell lines","pmids":["28575017"],"confidence":"Medium","gaps":["No reconstitution of RAB3GAP2 enzymatic role in secretion","Direct versus indirect transcriptional control not distinguished"]},{"year":2025,"claim":"Lens cell models defined a signaling axis by which RAB3GAP2 restrains JNK/STAT3-driven Mfn2-mediated mitophagy, explaining its protective role against oxidative stress and apoptosis.","evidence":"siRNA silencing in NaIO3-induced cataract cell and mouse models with JNK inhibitor and Mfn2 rescue, ROS and mitochondrial membrane potential assays","pmids":["41271057"],"confidence":"Medium","gaps":["Molecular step linking RAB3GAP2 to JNK activation not defined","Whether the effect requires GAP activity is untested"]},{"year":2026,"claim":"Endothelial studies established RAB3GAP2 as a negative regulator of proliferation and angiogenesis, expanding its role to vascular biology and secreted angiogenic factor control.","evidence":"siRNA knockdown in human endothelial cells, in vitro proliferation/tube formation, in vivo mouse endothelial density, secretome proteomics and eQTL analysis","pmids":["41678332"],"confidence":"Medium","gaps":["RAB18 involvement is only suggested, not demonstrated mechanistically","Direct link between GAP activity and angiogenic factor secretion unestablished"]},{"year":2026,"claim":"A splice-site variant causing exon 3 skipping demonstrated a concrete loss-of-function mechanism for pathogenic RAB3GAP2 alleles.","evidence":"Patient leukocyte RT-PCR and minigene splicing assay in HEK293T and HeLa cells","pmids":["42106822"],"confidence":"Medium","gaps":["Truncated protein product not directly detected or functionally assayed","Tissue-specific consequences not measured"]},{"year":null,"claim":"It remains unresolved how RAB3GAP2's non-catalytic role within the complex mechanistically couples its established cellular functions (autophagy, angiogenesis, mitophagy) to specific RAB substrates.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the RAB3GAP2/RAB3GAP1 complex in the corpus","RAB substrate specificity underlying the autophagy and endothelial phenotypes not defined","Direct biochemical assay of RAB3GAP2 contribution to GAP activity absent"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,2]}],"localization":[{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[0]}],"complexes":["RAB3GAP complex"],"partners":["RAB3GAP1","RAB18"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H2M9","full_name":"Rab3 GTPase-activating protein non-catalytic subunit","aliases":["RGAP-iso","Rab3 GTPase-activating protein 150 kDa subunit","Rab3-GAP p150","Rab3-GAP150","Rab3-GAP regulatory subunit"],"length_aa":1393,"mass_kda":156.0,"function":"Regulatory subunit of the Rab3 GTPase-activating (Rab3GAP) complex composed of RAB3GAP1 and RAB3GAP2, which accelerates the otherwise slow GTP hydrolysis catalyzed by Rab proteins (PubMed:9733780, PubMed:39779760). The complex has GTPase-activating protein (GAP) activity towards various Rab3 subfamily members (RAB3A, RAB3B, RAB3C and RAB3D), RAB5A and RAB43, and has guanine nucleotide exchange factor (GEF) activity towards RAB18 (PubMed:9733780, PubMed:39779760, PubMed:24891604). The Rab3GAP complex acts as a GEF for RAB18 by promoting GDP release from RAB18 and the conversion of inactive RAB18-GDP to the active form RAB18-GTP (PubMed:39779760, PubMed:24891604). Recruits and stabilizes RAB18 at the cis-Golgi membrane in human fibroblasts where RAB18 is most likely activated (PubMed:26063829). Also involved in RAB18 recruitment at the endoplasmic reticulum (ER) membrane where it maintains proper ER structure (PubMed:24891604). Required for normal eye and brain development (By similarity). May participate in neurodevelopmental processes such as cell proliferation, migration and differentiation before synapse formation, and non-synaptic vesicular release of neurotransmitters (By similarity)","subcellular_location":"Cytoplasm; Endoplasmic reticulum","url":"https://www.uniprot.org/uniprotkb/Q9H2M9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RAB3GAP2","classification":"Not Classified","n_dependent_lines":41,"n_total_lines":1208,"dependency_fraction":0.03394039735099338},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000118873","cell_line_id":"CID000435","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"golgi","grade":3},{"compartment":"vesicles","grade":2}],"interactors":[{"gene":"RAB3GAP1","stoichiometry":10.0},{"gene":"COPA","stoichiometry":0.2},{"gene":"COPB2","stoichiometry":0.2},{"gene":"COPE","stoichiometry":0.2},{"gene":"VAPB","stoichiometry":0.2},{"gene":"VAPA","stoichiometry":0.2},{"gene":"YIPF5","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000435","total_profiled":1310},"omim":[{"mim_id":"619420","title":"MARTSOLF SYNDROME 2; MARTS2","url":"https://www.omim.org/entry/619420"},{"mim_id":"616113","title":"POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS","url":"https://www.omim.org/entry/616113"},{"mim_id":"615663","title":"WARBURG MICRO SYNDROME 4; WARBM4","url":"https://www.omim.org/entry/615663"},{"mim_id":"614225","title":"WARBURG MICRO SYNDROME 2; WARBM2","url":"https://www.omim.org/entry/614225"},{"mim_id":"614222","title":"WARBURG MICRO SYNDROME 3; WARBM3","url":"https://www.omim.org/entry/614222"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RAB3GAP2"},"hgnc":{"alias_symbol":["RAB3-GAP150","KIAA0839","DKFZP434D245","SPG69"],"prev_symbol":[]},"alphafold":{"accession":"Q9H2M9","domains":[{"cath_id":"-","chopping":"555-629","consensus_level":"high","plddt":83.5089,"start":555,"end":629},{"cath_id":"-","chopping":"997-1182","consensus_level":"high","plddt":92.4301,"start":997,"end":1182},{"cath_id":"-","chopping":"1297-1393","consensus_level":"medium","plddt":80.8833,"start":1297,"end":1393}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H2M9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H2M9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H2M9-F1-predicted_aligned_error_v6.png","plddt_mean":79.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RAB3GAP2","jax_strain_url":"https://www.jax.org/strain/search?query=RAB3GAP2"},"sequence":{"accession":"Q9H2M9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H2M9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H2M9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H2M9"}},"corpus_meta":[{"pmid":"23420520","id":"PMC_23420520","title":"Mutation spectrum in RAB3GAP1, RAB3GAP2, and RAB18 and genotype-phenotype correlations in warburg micro syndrome and Martsolf syndrome.","date":"2013","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/23420520","citation_count":110,"is_preprint":false},{"pmid":"25495476","id":"PMC_25495476","title":"RAB3GAP1 and RAB3GAP2 modulate basal and rapamycin-induced autophagy.","date":"2014","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/25495476","citation_count":75,"is_preprint":false},{"pmid":"20967465","id":"PMC_20967465","title":"A homozygous RAB3GAP2 mutation causes Warburg Micro syndrome.","date":"2010","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20967465","citation_count":72,"is_preprint":false},{"pmid":"23176487","id":"PMC_23176487","title":"RAB3GAP1, RAB3GAP2 and RAB18: disease genes in Micro and Martsolf syndromes.","date":"2012","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/23176487","citation_count":23,"is_preprint":false},{"pmid":"28575017","id":"PMC_28575017","title":"FOXC1 modulates MYOC secretion through regulation of the exocytic proteins RAB3GAP1, RAB3GAP2 and SNAP25.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28575017","citation_count":9,"is_preprint":false},{"pmid":"32376645","id":"PMC_32376645","title":"Hypogonadotropic hypogonadism due to variants in RAB3GAP2: expanding the phenotypic and genotypic spectrum of Martsolf syndrome.","date":"2020","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/32376645","citation_count":6,"is_preprint":false},{"pmid":"29419336","id":"PMC_29419336","title":"Case report of four siblings in southeast Turkey with a novel RAB3GAP2 splice site mutation: Warburg micro syndrome or Martsolf syndrome?","date":"2018","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29419336","citation_count":6,"is_preprint":false},{"pmid":"39607444","id":"PMC_39607444","title":"Three Iranian patients with rare subtypes of hereditary spastic paraplegia (HSP): SPG76, SPG56, and SPG69.","date":"2024","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/39607444","citation_count":2,"is_preprint":false},{"pmid":"39838474","id":"PMC_39838474","title":"RAB3GAP2 dysregulation in adult T-cell leukemia/lymphoma (ATLL) compared to acute lymphoblastic leukemia (ALL): a molecular perspective.","date":"2025","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/39838474","citation_count":1,"is_preprint":false},{"pmid":"41678332","id":"PMC_41678332","title":"RAB3GAP2 is a regulator of skeletal muscle endothelial cell proliferation and associated with capillary-to-fiber ratio.","date":"2026","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/41678332","citation_count":0,"is_preprint":false},{"pmid":"41271057","id":"PMC_41271057","title":"RAB3GAP2 silencing alleviates oxidative stress in cataracts by enhancing Mfn2-mediated mitochondrial autophagy by activating JNK/STAT3.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41271057","citation_count":0,"is_preprint":false},{"pmid":"42106822","id":"PMC_42106822","title":"Functional analysis of a novel splice site variant of RAB3GAP2 in a fetus with congenital cataracts.","date":"2026","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/42106822","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8538,"output_tokens":2021,"usd":0.027964,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8961,"output_tokens":2520,"usd":0.053902,"stage2_stop_reason":"end_turn"},"total_usd":0.081866,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2014,\n      \"finding\": \"RAB3GAP1 and RAB3GAP2 form a complex (RAB3GAP complex) that modulates autophagosomal biogenesis at basal and rapamycin-induced conditions; their autophagy modulatory activity depends on the GTPase-activating activity of RAB3GAP1 but is independent of the RAB GTPase RAB3. Significant levels of RAB3GAP1/2 colocalize with Atg8 family members at lipid droplets.\",\n      \"method\": \"C. elegans genetics and human primary fibroblasts; correlation with ATG3, ATG16L1, ATG5 puncta analysis; colocalization imaging; epistasis with FEZ1/FEZ2\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (genetic epistasis in C. elegans, fibroblast KD, colocalization, autophagy marker analysis), single lab\",\n      \"pmids\": [\"25495476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FOXC1 positively regulates RAB3GAP2 (and RAB3GAP1) expression, and this regulation affects secretion of Myocilin (MYOC); modulation of RAB3GAP2 expression by FOXC1 links it to exocytosis/endocytosis pathways relevant to glaucoma.\",\n      \"method\": \"Biochemical and molecular techniques including gene expression manipulation (FOXC1 level alteration) and MYOC secretion assays in ocular cell lines\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — multiple biochemical/molecular methods in one lab; transcriptional regulation and secretion assays, but no direct mechanistic reconstitution of RAB3GAP2 activity\",\n      \"pmids\": [\"28575017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"RAB3GAP2 is expressed predominantly in skeletal muscle microvascular endothelium and acts as a negative regulator of endothelial cell proliferation and angiogenesis; experimental knockdown of RAB3GAP2 in human endothelial cells increased proliferation, tube formation in vitro, and in vivo endothelial cell density in mice, and regulated secreted angiogenic factors (CD70, TNC), possibly mediated through RAB18.\",\n      \"method\": \"siRNA knockdown in human endothelial cells; in vitro proliferation and tube formation assays; in vivo mouse endothelial density measurement; secretome/proteomics of conditioned medium; eQTL analysis; immunofluorescence localization\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined cellular phenotype, in vitro and in vivo validation, secretome analysis, single lab\",\n      \"pmids\": [\"41678332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"RAB3GAP2 silencing in lens epithelial cell cataract models activates the JNK/STAT3 signaling pathway, increasing Mfn2 transcription and promoting Mfn2-mediated mitochondrial autophagy, thereby reducing oxidative stress and apoptosis; inhibition of JNK (SP600125) or Mfn2 silencing abrogated these effects both in vitro and in a mouse cataract model.\",\n      \"method\": \"siRNA silencing in NaIO3-induced cataract cell models and mouse cataract model; RNA sequencing; JNK inhibitor (SP600125); Mfn2 siRNA; ROS and mitochondrial membrane potential assays; STAT3 nuclear translocation; in vivo mouse experiments\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal in vitro and in vivo methods with inhibitor and genetic rescue controls, single lab\",\n      \"pmids\": [\"41271057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"A RAB3GAP2 splice site variant (c.304+5G>T) causes aberrant splicing with exon 3 skipping, demonstrated by RT-PCR in patient leukocytes and a minigene assay in HEK293T and HeLa cells, predicting a truncated, loss-of-function protein.\",\n      \"method\": \"RT-PCR on patient peripheral blood; minigene splicing assay in HEK293T and HeLa cells; bioinformatics splice prediction tools\",\n      \"journal\": \"BMC medical genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — minigene functional assay with patient RT-PCR confirmation, two cell lines tested, single lab\",\n      \"pmids\": [\"42106822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Genotype-phenotype analysis of mutations in RAB3GAP1, RAB3GAP2, and RAB18 established that loss-of-function mutations in RAB3GAP2 cause Warburg Micro syndrome, while hypomorphic (milder) RAB3GAP2 mutations cause the less severe Martsolf syndrome, indicating a phenotypic severity continuum determined by the nature of the mutation and residual protein function.\",\n      \"method\": \"Mutational analysis of 144 Micro and 9 Martsolf families; Leiden Open source Variation Database curation; genotype-phenotype correlation\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Strong — large multi-family genetic study establishing genotype-phenotype relationships, replicated across many families, but no direct biochemical functional assay of RAB3GAP2 activity\",\n      \"pmids\": [\"23420520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A homozygous in-frame deletion in RAB3GAP2 (p.Phe167_Thr169del) causes Warburg Micro syndrome, demonstrating that functionally severe RAB3GAP2 mutations (not only hypomorphic ones) can produce the full Micro syndrome phenotype, establishing that RAB3GAP2 loss-of-function severity determines clinical outcome.\",\n      \"method\": \"Sanger sequencing of RAB3GAP2 in a consanguineous family; clinical phenotyping\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single family genetic finding, no direct biochemical assay of mutant protein function\",\n      \"pmids\": [\"20967465\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RAB3GAP2 is the non-catalytic regulatory subunit of the RAB3GAP complex (with RAB3GAP1 as the catalytic subunit); together they act as a GTPase-activating protein for RAB3 in regulated exocytosis of neurotransmitters and hormones, modulate autophagosomal biogenesis in a RAB3-independent but RAB3GAP1 GTPase activity-dependent manner, function as a negative regulator of endothelial cell proliferation and angiogenesis (possibly via RAB18), and in lens cells suppress oxidative stress by restraining JNK/STAT3-driven Mfn2-mediated mitochondrial autophagy; loss-of-function or hypomorphic mutations in RAB3GAP2 cause Warburg Micro syndrome or the milder Martsolf syndrome depending on the severity of residual protein function.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RAB3GAP2 is a regulatory component of the RAB3GAP complex that links RAB GTPase regulation to autophagy, secretion, and vascular and lens cell homeostasis [#0, #2]. Together with RAB3GAP1, it modulates autophagosomal biogenesis under basal and rapamycin-induced conditions in a manner that depends on the GTPase-activating activity of RAB3GAP1 but is independent of RAB3, with the complex colocalizing with Atg8-family members at lipid droplets [#0]. Its expression is positively controlled by the transcription factor FOXC1, coupling it to Myocilin secretion and ocular exocytic/endocytic pathways relevant to glaucoma [#1]. In skeletal muscle microvascular endothelium, RAB3GAP2 acts as a negative regulator of endothelial proliferation and angiogenesis, restraining tube formation and the secretion of angiogenic factors including CD70 and TNC, possibly through RAB18 [#2]. In lens epithelial cells it suppresses oxidative stress and apoptosis by restraining JNK/STAT3 signaling that drives Mfn2 transcription and Mfn2-mediated mitochondrial autophagy [#3]. Loss-of-function mutations in RAB3GAP2 cause Warburg Micro syndrome, whereas milder hypomorphic mutations cause Martsolf syndrome, defining a severity continuum set by residual protein function [#5, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing that a severe RAB3GAP2 lesion can produce disease addressed whether RAB3GAP2 mutation alone causes the full Micro syndrome phenotype.\",\n      \"evidence\": \"Sanger sequencing of an in-frame deletion in a consanguineous family with clinical phenotyping\",\n      \"pmids\": [\"20967465\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single family; no biochemical assay of the mutant protein's activity\", \"Does not define the molecular function disrupted by the deletion\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Genotype-phenotype correlation across many families resolved how mutation severity maps onto clinical outcome, establishing the Micro/Martsolf continuum.\",\n      \"evidence\": \"Mutational analysis of 144 Micro and 9 Martsolf families with variant database curation\",\n      \"pmids\": [\"23420520\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct biochemical assay of RAB3GAP2 activity\", \"Mechanism connecting residual function to phenotype severity not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that the RAB3GAP complex modulates autophagosome biogenesis revealed a cellular function beyond RAB3 regulation, dependent on RAB3GAP1 catalytic activity but independent of RAB3.\",\n      \"evidence\": \"C. elegans genetics, human fibroblast knockdown, autophagy marker puncta analysis, and lipid droplet colocalization\",\n      \"pmids\": [\"25495476\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The relevant RAB substrate for autophagy is unidentified\", \"Specific contribution of RAB3GAP2 versus RAB3GAP1 to the autophagy phenotype not separated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identifying FOXC1 as a positive regulator of RAB3GAP2 expression connected the gene to transcriptional control of ocular secretion and glaucoma-relevant Myocilin handling.\",\n      \"evidence\": \"FOXC1 level manipulation and Myocilin secretion assays in ocular cell lines\",\n      \"pmids\": [\"28575017\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No reconstitution of RAB3GAP2 enzymatic role in secretion\", \"Direct versus indirect transcriptional control not distinguished\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Lens cell models defined a signaling axis by which RAB3GAP2 restrains JNK/STAT3-driven Mfn2-mediated mitophagy, explaining its protective role against oxidative stress and apoptosis.\",\n      \"evidence\": \"siRNA silencing in NaIO3-induced cataract cell and mouse models with JNK inhibitor and Mfn2 rescue, ROS and mitochondrial membrane potential assays\",\n      \"pmids\": [\"41271057\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular step linking RAB3GAP2 to JNK activation not defined\", \"Whether the effect requires GAP activity is untested\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Endothelial studies established RAB3GAP2 as a negative regulator of proliferation and angiogenesis, expanding its role to vascular biology and secreted angiogenic factor control.\",\n      \"evidence\": \"siRNA knockdown in human endothelial cells, in vitro proliferation/tube formation, in vivo mouse endothelial density, secretome proteomics and eQTL analysis\",\n      \"pmids\": [\"41678332\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"RAB18 involvement is only suggested, not demonstrated mechanistically\", \"Direct link between GAP activity and angiogenic factor secretion unestablished\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"A splice-site variant causing exon 3 skipping demonstrated a concrete loss-of-function mechanism for pathogenic RAB3GAP2 alleles.\",\n      \"evidence\": \"Patient leukocyte RT-PCR and minigene splicing assay in HEK293T and HeLa cells\",\n      \"pmids\": [\"42106822\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Truncated protein product not directly detected or functionally assayed\", \"Tissue-specific consequences not measured\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how RAB3GAP2's non-catalytic role within the complex mechanistically couples its established cellular functions (autophagy, angiogenesis, mitophagy) to specific RAB substrates.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of the RAB3GAP2/RAB3GAP1 complex in the corpus\", \"RAB substrate specificity underlying the autophagy and endothelial phenotypes not defined\", \"Direct biochemical assay of RAB3GAP2 contribution to GAP activity absent\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [\"RAB3GAP complex\"],\n    \"partners\": [\"RAB3GAP1\", \"RAB18\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}